Immune checkpoint inhibitors of PD-L1 as cancer therapeutics | Journal of Hematology & Oncology | Full Text
IJMS | Free Full-Text | Navigating through the PD-1/PDL-1 Landscape: A Systematic Review and Meta-Analysis of Clinical Outcomes in Hepatocellular Carcinoma and Their Influence on Immunotherapy and Tumor Microenvironment
Biomedicines | Free Full-Text | PD-1/PD-L1 Pathway: A Therapeutic Target in CD30+ Large Cell Lymphomas
A snapshot of the PD-1/PD-L1 pathway
The roles of PD-1/PD-L1 in the prognosis and immunotherapy of prostate cancer - ScienceDirect
The importance of exosomal PDL1 in tumour immune evasion | Nature Reviews Immunology
PD−L1 immunostaining: what pathologists need to know | Diagnostic Pathology | Full Text
Emerging Role of Ubiquitination in the Regulation of PD-1/PD-L1 in Cancer Immunotherapy - ScienceDirect
PDL1 e immunoterapici | L'immunologo risponde | alcase.eu
PD−L1 immunostaining: what pathologists need to know | Diagnostic Pathology | Full Text
Mechanistic insight of predictive biomarkers for antitumor PD‑1/PD‑L1 blockade: A paradigm shift towards immunome evaluation (Review)
Cancer: anti-PD-1 / PD-L1 antibodies, new solutions for immunotherapy
Studio di PD-L1 e di altri predittori di efficacia per l'immunoterapia nel carcinoma non a piccole cellule del polmone in stadio avanzato | martaliveonlus.org
PD-1 PD-L1 Pathway in Cancer
Frontiers | Adverse Effects of Anti-PD-1/PD-L1 Therapy in Non-small Cell Lung Cancer
Are PD-1 and PD-L1 Checkpoint Inhibitors As Good As We Thought?
Frontiers | Noncanonical PD-1/PD-L1 Axis in Relation to the Efficacy of Anti-PD Therapy
Peptide for Determination of PDL1 Expression in Tumors | LifeTein Peptide Blog
Release the B7.1! Anti-PD-L1 breaks PD-L1's grip
Mechanism of action of PD-1 and PD-L1 inhibitors. The programmed cell... | Download Scientific Diagram
Identification and Validation of a PD-L1 Binding Peptide for Determination of PDL1 Expression in Tumors | Scientific Reports
Frontiers | Resistance Mechanisms of Anti-PD1/PDL1 Therapy in Solid Tumors